. . . . . . . "[Using salubrinal and guanabenz as an inhibitory agent of dephosphorylation of eIF2?, we addressed a question whether an elevated level of phosphorylated eIF2? attenuates malignant phenotypes of triple negative breast cancer cells (TNBCs) that lack estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:28+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .